• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[食管胃交界腺癌的Siewert-Stein分类]

[Siewert-Stein classification of adenocarcinoma of the esophagogastric junction].

作者信息

Szántó I, Vörös A, Gonda G, Nagy P, Altorjay A, Banai J, Gamal E M, Cserepes E

机构信息

Semmelweis Egyetem, ETK, Sebészeti Klinika, 1389 Budapest, Pf 112. Szabolcs u. 35.

出版信息

Magy Seb. 2001 Jun;54(3):144-9.

PMID:11432164
Abstract

Nowadays the terminology used for the definition of adenocarcinomas at the oesophagogastric junction is "cardiac carcinoma", which can be easily misunderstood. This definition of adenocarcinomas of the oesophagogastric junction does not allow correct comparison of diagnosis (endoscopic, radiological and pathologic), epidemiology and surgical therapy in national and international aspects, because different tumours can develope in the same area, and all called cardia tumors. Siewert and Stein recommended a classification to solve this problem. The classification of the tumours is morphological/topographical. Type I is adenocarcinoma of the distal part of the oesophagus. Type II is adenocarcinoma of the real cardia and type III is subcardial gastric adenocarcinoma. At classification, we always consider results of endoscopy (ortograde and retroflexed view of the oesophago-gastric junction), the x-rays of the oesophagus and stomach, findings at the operation and pathohistologic results. Between 1/1/1974 and 31/12/2000, a total number of 50,878 upper panendoscopic examinations were performed at the Endoscopic Laboratory of the Surgical Department. Adenocarcinoma of the cardia was diagnosed in 488 patients. According to the Siewert-Stein classification, type I tumour was found in 123 (25.2%), type II in 240 (49.18%), and type III was present in 125 (25.61%) patients. The importance of this classification is it enables unified pre-operative assessment and it can also help to decide the type of the surgical intervention. In our patients with type I cancer--depending of the size of the tumour--distal 2/3 oesophagectomy with the resection of the proximal lesser curve of the stomach or total gastrectomy were performed. In the first group oesophago-jejuno-gastrostomy, in case of total gastrectomy Roux-en-Y loop anastomosis was created. In patients with types II and III cancers total gastrectomy was performed. In every patient lymphadenectomy was performed. We suggest the use of this new classification in clinical, gastroenterology--with special regard to the endoscopy--and pathology.

摘要

如今,用于定义食管胃交界腺癌的术语是“贲门癌”,这很容易引起误解。这种食管胃交界腺癌的定义不利于在国家和国际层面上对诊断(内镜、放射学和病理学)、流行病学及手术治疗进行正确比较,因为同一区域可能发生不同肿瘤,且都被称为贲门肿瘤。Siewert和Stein推荐了一种分类方法来解决这个问题。肿瘤的分类是形态学/局部解剖学的。I型是食管远端腺癌。II型是真正贲门的腺癌,III型是贲门下方的胃腺癌。在分类时,我们始终会考虑内镜检查结果(食管胃交界的顺行和逆行观察)、食管和胃的X线检查、手术所见以及病理组织学结果。在1974年1月1日至2000年12月31日期间,外科内镜实验室共进行了50878例上消化道内镜检查。488例患者被诊断为贲门腺癌。根据Siewert-Stein分类,I型肿瘤有123例(25.2%),II型有240例(49.18%),III型有125例(25.61%)。这种分类的重要性在于它能实现统一的术前评估,还有助于决定手术干预的类型。对于我们的I型癌症患者,根据肿瘤大小,进行食管远端2/3切除术并切除胃近端小弯或全胃切除术。第一组进行食管空肠胃吻合术,全胃切除时则行Roux-en-Y袢吻合术。对于II型和III型癌症患者则进行全胃切除术。每位患者均进行淋巴结清扫术。我们建议在临床、胃肠病学(尤其在内镜检查方面)及病理学中使用这种新分类。

相似文献

1
[Siewert-Stein classification of adenocarcinoma of the esophagogastric junction].[食管胃交界腺癌的Siewert-Stein分类]
Magy Seb. 2001 Jun;54(3):144-9.
2
Classification, diagnosis and surgical treatment of carcinomas of the gastroesophageal junction.胃食管交界部癌的分类、诊断及外科治疗
Hepatogastroenterology. 2001 Sep-Oct;48(41):1231-7.
3
Individualized surgical strategies for cancer of the esophagogastric junction.食管胃交界部癌的个体化手术策略
Ann Chir Gynaecol. 2000;89(3):191-8.
4
Adenocarcinoma of the Esophagogastric Junction in China according to Siewert's classification.中国食管胃交界腺癌的Siewert分类
Jpn J Clin Oncol. 2006 Jun;36(6):364-7. doi: 10.1093/jjco/hyl042. Epub 2006 Jun 9.
5
[Diagnostics and clinical significance of esophageal metastasis of adenocarcinoma of the gastroesophageal junction].[胃食管交界腺癌食管转移的诊断及临床意义]
Orv Hetil. 2004 Jan 18;145(3):99-104.
6
Biologic and clinical variations of adenocarcinoma at the esophago-gastric junction: relevance of a topographic-anatomic subclassification.食管胃交界腺癌的生物学和临床变异:地形解剖亚分类的相关性
J Surg Oncol. 2005 Jun 1;90(3):139-46; discussion 146. doi: 10.1002/jso.20218.
7
Is adenocarcinoma of the gastric cardia a distinct entity independent of subcardial carcinoma?贲门腺癌是否是一种独立于贲门下方癌的独特实体?
World J Surg. 2003 Mar;27(3):334-8. doi: 10.1007/s00268-002-6776-8. Epub 2003 Feb 27.
8
[New classification for adenocarcinoma of the esophagogastric junction in China].[中国食管胃交界腺癌的新分类]
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2007 Feb;32(1):138-43.
9
[Surgical resection in esophageal-gastric junction adenocarcinoma].[食管胃交界腺癌的手术切除]
Rev Med Chir Soc Med Nat Iasi. 2006 Jan-Mar;110(1):122-7.
10
[Clinical and pathological prognostic factors for cancers of the esophagogastric junction].[食管胃交界部癌的临床和病理预后因素]
Zentralbl Chir. 2009 Sep;134(5):455-61. doi: 10.1055/s-0029-1224512. Epub 2009 Sep 15.

引用本文的文献

1
Pre-operative beta-blocker therapy does not affect short-term mortality after esophageal resection for cancer.术前β受体阻滞剂治疗并不影响食管癌切除术后的短期死亡率。
BMC Surg. 2020 Dec 22;20(1):333. doi: 10.1186/s12893-020-01017-x.
2
Clinical application and observation of modified Ivor-Lewis surgery in Siewert type II adenocarcinoma of the Esophagogastric junction.改良Ivor-Lewis手术在食管胃交界部Siewert II型腺癌中的临床应用与观察
J Cardiothorac Surg. 2019 Nov 27;14(1):207. doi: 10.1186/s13019-019-1023-7.
3
Effect of the Addition of Cetuximab to Paclitaxel, Cisplatin, and Radiation Therapy for Patients With Esophageal Cancer: The NRG Oncology RTOG 0436 Phase 3 Randomized Clinical Trial.
厄洛替尼联合紫杉醇、顺铂和放疗治疗食管癌患者的效果:NRG 肿瘤学 RTOG 0436 期随机临床试验。
JAMA Oncol. 2017 Nov 1;3(11):1520-1528. doi: 10.1001/jamaoncol.2017.1598.
4
Epidemiology of esophageal cancer.食管癌的流行病学。
World J Gastroenterol. 2013 Sep 14;19(34):5598-606. doi: 10.3748/wjg.v19.i34.5598.